VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,794 | -39.2% | 28,193 | -7.2% | 0.00% | 0.0% |
| Q2 2023 | $200,224 | -2.9% | 30,383 | -0.0% | 0.00% | 0.0% |
| Q1 2023 | $206,307 | -7.7% | 30,384 | +0.5% | 0.00% | -50.0% |
| Q4 2022 | $223,518 | -25.7% | 30,246 | -0.8% | 0.00% | 0.0% |
| Q3 2022 | $301,000 | -8.5% | 30,483 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $329,000 | -7.6% | 30,148 | -4.2% | 0.00% | 0.0% |
| Q1 2022 | $356,000 | -32.1% | 31,463 | -5.8% | 0.00% | -33.3% |
| Q4 2021 | $524,000 | -11.3% | 33,390 | -3.1% | 0.00% | 0.0% |
| Q3 2021 | $591,000 | -22.9% | 34,458 | -3.3% | 0.00% | 0.0% |
| Q2 2021 | $767,000 | -18.8% | 35,651 | -43.3% | 0.00% | 0.0% |
| Q1 2021 | $944,000 | +7.5% | 62,875 | -6.0% | 0.00% | 0.0% |
| Q4 2020 | $878,000 | +144.6% | 66,855 | +79.8% | 0.00% | +50.0% |
| Q3 2020 | $359,000 | -17.5% | 37,182 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $435,000 | +16.9% | 38,058 | +5.9% | 0.00% | 0.0% |
| Q1 2020 | $372,000 | -39.9% | 35,939 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $619,000 | +20.4% | 37,719 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $514,000 | -6.9% | 38,741 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $552,000 | -23.0% | 39,143 | +0.5% | 0.00% | -33.3% |
| Q1 2019 | $717,000 | -31.4% | 38,949 | -2.6% | 0.00% | -25.0% |
| Q4 2018 | $1,045,000 | +33.6% | 39,981 | +17.4% | 0.00% | +33.3% |
| Q3 2018 | $782,000 | +22.8% | 34,065 | +1.8% | 0.00% | +50.0% |
| Q2 2018 | $637,000 | +34.4% | 33,452 | +18.8% | 0.00% | 0.0% |
| Q1 2018 | $474,000 | +5.1% | 28,152 | -5.1% | 0.00% | +100.0% |
| Q4 2017 | $451,000 | -14.7% | 29,666 | +0.5% | 0.00% | -50.0% |
| Q3 2017 | $529,000 | +18.9% | 29,526 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $445,000 | +40.8% | 27,318 | +21.1% | 0.00% | +100.0% |
| Q1 2017 | $316,000 | -6.0% | 22,563 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $336,000 | -99.9% | 21,072 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $351,553,000 | +48.9% | 21,127 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $236,053,000 | +15.1% | 21,095 | -13.8% | 0.00% | 0.0% |
| Q1 2016 | $205,000,000 | -10.1% | 24,481 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $228,000,000 | +82210.5% | 24,481 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $277,000 | -99.9% | 24,524 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $310,842,000 | +32.8% | 24,495 | -2.6% | 0.00% | 0.0% |
| Q1 2015 | $233,997,000 | -35.1% | 25,161 | 0.0% | 0.00% | -50.0% |
| Q4 2014 | $360,306,000 | +48.5% | 25,161 | +7.7% | 0.00% | +100.0% |
| Q3 2014 | $242,601,000 | -35.9% | 23,372 | -0.1% | 0.00% | -50.0% |
| Q2 2014 | $378,434,000 | +3.3% | 23,389 | +3.7% | 0.00% | 0.0% |
| Q1 2014 | $366,438,000 | +34.2% | 22,550 | +2.5% | 0.00% | +100.0% |
| Q4 2013 | $273,132,000 | +31.0% | 22,009 | +15.8% | 0.00% | 0.0% |
| Q3 2013 | $208,452,000 | +32.7% | 19,002 | -2.3% | 0.00% | 0.0% |
| Q2 2013 | $157,083,000 | – | 19,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |